Authors: Klinger, G Graser, T Mellinger, U Moore, C Vogelsang, H Groh, A Latterman, C Klinger, G

Citation: G. Klinger et al., A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system, GYNECOL END, 14(1), 2000, pp. 15-24

Authors: Graser, T Muller, A Mellinger, U Muck, AO Lippert, TH Oettel, M

Citation: T. Graser et al., Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study, MATURITAS, 35(3), 2000, pp. 253-261

Authors: Moore, C Carol, W Graser, T Mellinger, U Walter, F

Citation: C. Moore et al., Influence of dienogest on ovulation in young fertile women, CLIN DRUG I, 18(4), 1999, pp. 271-278

Authors: Zimmermann, H Duvauchelle, T Gualano, V Kaufmann, G Bervoas-Martin, S Breitbarth, H Mathieu, M Mellinger, U Ntsikoussalabongui, B Oettel, M Thebault, JJ

Citation: H. Zimmermann et al., Pharmacokinetics of dienogest as a single drug or in combination with estradiol valerate or ethinylestradiol, DRUGS TODAY, 35, 1999, pp. 27-39

Authors: Moore, C Feichtinger, W Klinger, G Mellinger, U Spona, J Walter, F Winkler, UH Zahradnik, HP

Citation: C. Moore et al., Clinical findings with the dienogest-containing oral contraceptive Valette((R)), DRUGS TODAY, 35, 1999, pp. 53-68

Authors: Balogh, A Gessinger, S Svarovsky, U Hippius, M Mellinger, U Klinger, G Hoffmann, A Oettel, M

Citation: A. Balogh et al., Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?, EUR J CL PH, 54(9-10), 1998, pp. 729-734